leAD Toyoshima Boot Camp

OxiWear participated in the first-ever bootcamp for Asian sports and health tech startups in partnership with leAD and Toyoshima. The seminar included product and company introductions by Xenoma and Euphoria. A panel discussion with the CEO’s of KinoTek and OxiWear was facilitated by Alexander Bente, Principal, ADvantage Sports Tech Fund.

Read More »

MassMedic BIOMEDevice Boston 2021

OxiWear attended the MassMEDIC BIOMEDevice Boston 2021 convention held on September 21-22, 2021. We were thrilled to be chosen by Formlabs to receive a Formlabs3, 3D-printer package, as part of the company’s diversity and inclusion program in support of our founder and CEO. We look forward to using this new printer to assist us with designing and testing our product.

Read More »

OxiWear team starts in-person cohort at Lake Nona

After a month of virtual programming, the OxiWear team started their in-person experience with the leAD Sports & Health Tech accelerator in Lake Nona, Florida. The kick-off event was hosted on September 13, 2021, and included the new cohort companies, OxiWear, Kutai, IndiFit, Point, Sugi, and Flumina. The team enjoyed learning about the accelerator program as well as touring the Lake Nona Performance Sports Arena and Beep (an autonomous transportation company).

Read More »

OxiWear selected for the competitive leAD Sports & Health Tech Accelerator

OxiWear was selected for the second cohort of the leAD Sports & Health Tech accelerator to be held from August to December 2021 in Lake Nona, Florida. The first United State sponsored cohort featured six companies and was hosted in 2020. This year, 497 companies applied for the fall cohort and six were chosen. Since its inception in 2016, the leAD Sports & Health tech program has supported 30 startups overall.

Read More »

OxiWear conducts testing at UCSF Hypoxia Lab

In June, OxiWear engineers conducted hypoxia testing at the University of California – San Francisco, Hypoxia Lab.

The Hypoxia Lab has been conducting research since 1958 and was founded by John W. Severinghaus, Professor Emeritus, Department of Anesthesia and Perioperative Care, UCSF. Dr. Severinghaus was the inventor of modern blood gas analysis and has issued more than 200 peer reviewed publications in the gas exchange/gas transport field.

Read More »